Check out the new expanded preview site!
ONS: Oncology Nursing Society
Log In
Join
News
Calendar
Store
CNE Central
Clinical Practice
Membership
Publications
Chemotherapy Courses
Facebook
Twitter
YouTube
Twitter
CML
CML Overview
CML Physical Presentation
CML Phases
Treatment for CML
General Side Effects of TKIs
Patient Education Regarding TKIs
Patient Compliance to TKI Therapy
Monitoring Response to TKI Therapy
Advanced CML Treatment Options
New Clinical Trials
References
Awards, Grants & Scholarships
Legislation & Advocacy
Corporate Support
ONSEdge
Certification Makes a Difference Visit ONCC
Support the ONS Foundation Donate Now
Home
>
Clinical Practice Resources
>
CML
>
GENERAL SIDE EFFECTS OF TKIs
Imatinib has been shown to be teratogenic and embryotoxic in animals.
Dasatinib and nilotinib can cause embryonic or fetal toxicities in animals.
No evidence exists to support continuation of TKIs during pregnancy.
Advertisement
Advertisement
2-Day Chemo/Bio Course
Renewal Course
Update Course
Trainer Course
Treatment Basics
Safety Standards
Chemotherapy Courses FAQ